FDA Drug Recalls

Recalls / Class II

Class IID-0403-2024

Product

fentaNYL 2,500 mcg/50 mL in 0.9 % Sodium Chloride Injection (Concentration = 50 mcg/mL) 50 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0202-22, Bar code 70004020022,

Affected lot / code info
Lot #: 1223048959, Exp 12/11/23; 1223049009, Exp 12/12/23; 1223049170, Exp 12/20/23; 1223049245, Exp 12/22/23

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
SCA Pharmaceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
755 Rainbow Rd Ste B, N/A, Windsor, Connecticut 06095-1024

Distribution

Quantity
500 syringes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-11-09
FDA classified
2024-03-22
Posted by FDA
2024-04-03
Terminated
2024-08-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0403-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls